Abdulrahman Al Turaiki
Overview
Explore the profile of Abdulrahman Al Turaiki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elezbawy B, Fasseeh A, Fouly E, Tannira M, Dalle H, Aderian S, et al.
Dermatol Ther (Heidelb)
. 2022 Nov;
13(1):131-146.
PMID: 36445612
Introduction: Atopic dermatitis (AD) is a chronic skin disease that poses a significant burden on both patients and the society. AD causes the highest loss in disability-adjusted life years compared...
2.
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
Elezbawy B, Fasseeh A, Fouly E, Abu Esba L, Al Abdulkarim H, Al-Haddab M, et al.
J Med Econ
. 2022 Nov;
25(1):1231-1239.
PMID: 36426726
Atopic dermatitis (AD) is a chronic skin disease that creates a significant burden to patients and society. There is scarcity in local data about the burden of AD in the...
3.
Al Muqati H, Al Turaiki A, Al Dhahri F, Al Enazi H, Althemery A
J Infect Public Health
. 2021 Feb;
14(3):306-310.
PMID: 33618274
Background: Superinfection is a new isolate pathogen after 48 h of antibiotic treatment or within one week of treatment discontinuation. In many studies carbapenem and piperacillin-tazobactam were associated with high...
4.
Al Ammari M, Al Turaiki A, Al Essa M, Kashkary A, Eltigani S, Ahmed A
Antimicrob Resist Infect Control
. 2018 Feb;
7:12.
PMID: 29387346
Background: There is limited data that investigates the national rates of drug-resistant tuberculosis (TB) in Saudi Arabia.This study aimed to estimate the rates of multi-drug-resistant tuberculosis (MDR-TB), rifampicin-resistant tuberculosis (RR-TB),...